novo semaglutide alzheimer's An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of disease in closely watched trials, Nordisk… High-stakes Novo Nordisk Alzheimer's studies

May 30th, 2026 How AOD-9604 Supports Fat Metabolism AOD 9604 is a synthetic peptide fragment derived from human growth hormone that has shown potential in early research to support fat metabolism and weight loss, though its long-term safety, efficacy, and regulatory status remain uncertain

In a world of transparent, net-price-based distribution, the economics of brand-name drugs shift substantially

At Rheumatologist OnCall, our board-certified rheumatologists see patients in days, not months telehealth across 20 states, no referral required

Clinical data shows that most patients experience some weight regain after stopping GLP-1 therapy which is why our maintenance protocols and long-term support are built into every program from day one